Discrepancies Between the One-Stage Clotting Assay and Chromogenic Assay in Patients With Hemophilia a Receiving Standard or Extended Half-Life Factor VIII Products in Clinical Settings
Thrombosis Research - United Kingdom
doi 10.1016/j.thromres.2019.11.020
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2020
Authors
Publisher
Elsevier BV